• All
• March 28 (Thursday)
• March 29 (Friday)
• March 30 (Saturday)

Day-1 - March 28 (Thursday)

• Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim
  Sungkyunkwan University School of Medicine, Korea CV Abstract
• Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai
  St. Marianna University School of Medicine, Japan CV Abstract
• NK lymphoma genomics Weili Zhao
  Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China CV Abstract

Day-1 - March 28 (Thursday)

• Histiocytic neoplasm in pediatrics Kyung-Nam Koh
  University of Ulsan College of Medicine, Korea CV Abstract
• Histiocytic sarcoma Sungnam Lim
  Inje University College of Medicine, Korea CV Abstract
• Pathologic characteristics of histiocytic and dendritic cell neoplasms Sun Och Yoon
  Yonsei University College of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Elucidating the 3D chromatin landscape of pediatric B-cell acute lymphoblastic leukemia using Micro-C Kajsa Paulsson
  Lund University, Sweden CV Abstract
• Integrated RNA and protein profiling of B-cell acute lymphoblastic leukemia at single-cell level Sungyoung Choi
  Hanyang University College of Medicine, Korea CV Abstract
• Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasm Stephen T. Oh
  Washington University School of Medicine, USA CV Abstract

Day-1 - March 28 (Thursday)

• Molecular mechanism of primary TKI
  resistance in CML Jerald Radich
  Fred Hutchinson Cancer Center, USA CV Abstract
• Targeting leukemic stem cells in CML Mhairi Copland
  University of Glasgow, UK CV Abstract
• The role of NGS to detect TKI resistance Saeam Shin
  Yonsei University College of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell
  Wellcome Sanger Institute, UK CV Abstract

Day-1 - March 28 (Thursday)

• Lab-on-a-chip in hematology Chong H. Ahn
  University of Cincinnati, USA CV Abstract

Day-1 - March 28 (Thursday)

• Treatment of newly diagnosed multiple myeloma: Focus on daratumumab combination Elena Zamagni
  IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy CV Abstract

Day-1 - March 28 (Thursday)

• The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH Sung-Hyun Kim
  Dong-A University College of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Treatment strategies for elderly AML with FLT3-mutation, entering the Era of FLT3 Inhibitors Naoko Hosono
  University of Fukui, Japan CV Abstract

Day-1 - March 28 (Thursday)

• Advances in the treatment paradigm with bispecific antibodies Wendy Osborne
  Newcastle University, UK CV Abstract

Day-1 - March 28 (Thursday)

• Dynamic assessment of risk in multiple myeloma Meral Beksac
  Ankara Liv Hospital affiliated with Istinye University, Türkiye CV Abstract
• PET/CT for risk stratification in multiple myeloma Joon Ho Moon
  Kyungpook National University School of Medicine, Korea CV
• Bone marrow inflammation in multiple myeloma Tom Cupedo
  Erasmus MC Cancer Center, The Netherlands CV Abstract
• Single-cell analysis in multiple myeloma Sung-Soo Park
  The Catholic University of Korea College of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Approaches to treat people with hemophilia: What’s new and what’s not? Leonard A. Valentino
  Rush University, USA CV Abstract
• Prospects and challenges of gene therapy for hemophilia Alok Srivastava
  Christian Medical College, India CV Abstract
• Exploring personalized tailored hemophilia treatment: Tailoring treatment to individual needs Jeong A Park
  Inha University College of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• CD7 CAR-T therapy for treating hematological malignancies Peihua Lu
  Lu Daopei Hospital, China CV Abstract
• Development of a novel anti-CD19 CAR-T cells in B cell lymphoma Dok Hyun Yoon
  University of Ulsan College of Medicine, Korea CV Abstract
• CAR-T cells for treatment of T cell malignancies Paul M. Maciocia
  Cancer Research UK , UK CV Abstract

Day-1 - March 28 (Thursday)

• Navigating cancer complexities via single-cell omics and AI Manoj Bhasin
  Emory University, USA CV Abstract
• Targeting the developmental heterogeneity of human acute myeloid leukemia Shanshan Pei
  Zhejiang University, China CV Abstract
• Mutational profile in Korean AML patients Jae-Sook Ahn
  Chonnam National University Medical School, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Germinal center in the genesis of lymphomas Laura Pasqualucci
  Columbia University, USA CV
• Genomics of follicular lymphoma: Clinical implications? Robert Kridel
  University of Toronto, Canada CV Abstract
• Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: A multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression Jin Ho Paik
  Seoul National University College of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Molecular alterations and clinical implications in MDS Yasushi Miyazaki
  Nagasaki University, Japan CV Abstract
• Recent advances and future therapeutic strategies in MDS Guillermo Garcia-Manero
  The University of Texas MD Anderson Cancer Center, USA CV
• Current diagnostic challenges in MDS In-Suk Kim
  Pusan National University School of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• RUNX1-FPDMM natural history study at NIH Pu Paul Liu
  National Institutes of Health, USA CV Abstract
• Clinical impact of DDX41 mutations in myeloid neoplasms Talha Badar
  Mayo Clinic, USA CV Abstract
• Discovery of new regulators in hematopoietic stem cells and malignancies Dongjun Lee
  Pusan National University School of Medicine, Korea CV Abstract

Day-1 - March 28 (Thursday)

• Overview of lymphoma classification Tae-Jung Kim
  The Catholic University of Korea College of Medicine, Korea CV Abstract
• What's new in AML classification Hee Sue Park
  Chungbuk National University College of Medicine, Korea CV Abstract
• Recent update of MDS classification Miyoung Kim
  University of Ulsan College of Medicine, Korea CV Abstract